You are here
- Venture Capital 101 with Osage University Partners
Venture Capital 101 with Osage University Partners
Venture capital can take your invention from an idea to an innovation and then an IPO - if you can get it. Last year, U.S. venture capitalists invested about $10.7 billion in seed and early stage companies,* and venture capital has been demonstrated to have a strong positive impact on fostering innovation. While VC investment is on the rise, the number of start-ups has also exploded, and competition for VC dollars is fierce. In this video, John Lee, Matthew Cohen, Louis P. Berneman of Osage University Partners offer insight into the decision-making process for VC firms and shed light on what VC funding can do for your start-up.
This event was co-sponsored by the Office of Postdoctoral Affairs.
In this talk, Lee discusses how the healthcare field has changed over the past decades [3:10], why this is the right time for technology innovation [4:30], the simultaneous transformation of healthcare and venture capital [7:53], fundamental trends in healthcare technology [12:50], what Foundation Medical Partners does differently [15:25], whether the life-science tech model might improve [17:47], what to look for in a project when deciding whether to invest [21:52], who are the key players in the fee-for-service debate [24:20], why electronic medical records are a game-changer [27:15], why medical technology hasn’t progressed as quickly as expected [29:28], the role intellectual property and patents play in health technology [34:38], what the day-to-day life of a venture capitalist is like and what people can do early on to prepare for a career in venture capital [35:38], the role of accelerators in advancing technology [40:34], why healthcare lags behind other industries in technology [41:16], and alternative pathways for traditional approaches like drugs and devices to healthcare technology [42:41].
Louis P. Berneman is the founding partner of Osage University Partners (OUP), a venture capital firm that specializes in financing university spinouts commercializing disruptive science. Osage has partnered with 65+ universities and research institutions, including Columbia, to invest in their startups. OUP I ($100M) launched in 2011, has invested in 37 companies across all technology sectors, including software, hardware, and life sciences. OUP is now raising Fund II targeted at $200M. Osage focuses on transformative technologies, passionate entrepreneurs, and investing in companies solving major global challenges. Prior to OUP, Lou was managing director of the University of Pennsylvania Center for Technology Transfer. He is a past president of the Association of University Technology Managers (AUTM) and a serial entrepreneur.
* According to data from the National Venture Capital Association and PricewaterhouseCoopers Moneytree survey.